Mr. Edward Argar – a senior health official of England on 8/2 spoke up to protect the vaccine COVID-19 by pharmaceutical company AstraZeneca in the UK in cooperation with Oxford University, in the context of doubts about the effectiveness of this vaccine, especially after South Africa decided to temporarily stop using it.
Argar told Sky that there is no evidence that the Astrazeneca vaccine is ineffective in preventing the SARS-CoV-2 virus, leading to hospitalization or hospitalization. mortality risk. The UK variant of the SARS-CoV-2, he stressed, is not the same as the South African variant. He said that up to now, there are 147 people in the UK positive for the variant in South Africa.
The UK has the 5th highest number of COVID-19 deaths in the world. The country has so far vaccinated the first shot of COVID-19 to more than 12 million people, while about 500,000 have received a second shot.
Meanwhile, the emergence of new variants of the SARS-CoV-2 virus is causing many concerns that the original vaccinated vaccine may not be effective against the new variants. Currently, scientists and public health experts are particularly concerned about variants in the UK, South Africa and Brazil as all three appear to be contagious.
[Nam Phi tạm dừng tiêm chủng vắcxin của hãng AstraZeneca]
Australian Health Minister Greg Hunt has reassured people about the effectiveness of the AstraZeneca / Oxford vaccine, after South Africa stopped using the vaccine due to data showing limited effectiveness in its prevention. prevent a new variant of the SARS-CoV-2 virus.
According to the test results done by the University of Witwatersrand in Johannesburg (South Africa), Vaccine of AstraZeneca was only 22% preventive against the virus variant recognized in South Africa. So South Africa decided to stop using the vaccine and wait for the scientists’ recommendation about the next steps.
Australian Health Minister Greg Hunt emphasized to date there is no evidence of a decrease in the effectiveness of the AstraZeneca vaccine or the Pfizer / BioNTech vaccine in preventing severe illness or limiting the risk of death.
It is expected that in the next few days, Australia will approve AstraZeneca’s vaccine and have ordered 53 million doses of this vaccine. Last month, the country licensed the Pfizer / BioNTech vaccine. Australia will start giving residents Pfizer / BioNTech vaccines from the end of this month.